ArticleACS sensors2025
On the Blood Components Contributing to the Drift of Electrochemical Aptamer-Based Biosensors.
Article in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Rapid-Forming Conductive Antifouling Hydrogel Coating Enables Magnetically Guided Electrochemical POCT for Direct at‑Home Blood Testing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Real-Time Monitoring of Trastuzumab Monoclonal Antibodies Using Electrochemical Aptamer-Based Sensors.ACS sensors · 2026Article
- Dual-Channel Interdigitated Aptamer-Based Sensors for Rapid Small-Molecule Detection in Biofluids.Angewandte Chemie (International ed. in English) · 2026Article
- A robust Au-C[triple bond, length as m-dash]C anchoring group greatly improves the signal stability of electrochemical aptamer-based sensors forChemical science · 2026Article
- Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurement.Nature biotechnology · 2026Article
- Bridging sepsis physiology and biosensor engineering: a clinical perspective on electrochemical cytokine sensor design.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Electrochemical aptamer-based (EAB) sensors support the high-frequency, real-time measurement of specific molecules, including metabolites, pharmacological agents, and biomarkers, in situ in the living body. A challenge that complicates their long-term, in vivo deployment, however, is signal drift, which causes a reduction in their signal output over time that is unrelated to the presence of target. Previously, we and others have shown that, when placed in undiluted whole blood at body temperature, EAB sensor drift arises predominantly due to fouling and enzymatic degradation of the DNA aptamer, with the former dominating in vitro in days-old bovine blood, and the latter dominating in vivo in blood flowing through the rat jugular. Building on this background, here we explore the specific blood components that prompt the EAB sensor drift in vitro. Comparison of the drift produced by whole blood, washed blood cells, and plasma demonstrates that this drift is caused by blood proteins rather than blood cells. And studies employing size-fractionated serum and plasma indicate that the proteins causing drift are approximately of molecular weight >100 kDa. The latter observation explains past successes in mitigating drift via the use of molecular-weight-selective films.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.